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Introduction. On the 16th of January 2012, the Spanish Association Against Cancer (AECC) implemented the volunteer program
“Carrito Don Amable” in the Radiation Oncology Service of Meixoeiro Hospital of the University Hospital Center of Vigo (CHUVI)
with the aim of taking care the needs that are not met under the healthcare scope, both for the oncologic patients and for his
relatives. One year after its implementation, it will be carried out a quality assessment of the program, taking into account the
importance and the assessment of the attributes made by patients and relatives that are program beneﬁciaries.
Objective. Analyzing the quality of the program “Carrito DonAmable” of the AECC, implemented in the RadiationOncology Service
of the CHUVI through the IPA Technique (Importance-Performance Analysis) in a representative sample of program beneﬁciaries.
Methods. The IPA is a quality assessment technique based on the analysis of expectation together with the assessment of the
attributes of the applicable service. In this study, it is implemented a questionnaire fulﬁlled by a statistically signiﬁcant sample
of the patients and relatives beneﬁciaries of the program.
Results and conclusions. Quadrant graphics will represent those attributes of the program that could be improved, those that will
be improved as a priority, those attributes that could imply a waste of resources or those of low priority. We will measure the
general success of the program assessed by its beneﬁciaries, the patients and relatives.
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Introduction. The aggressive angiomyxoma is a rare tumor that arises in mesenchymal tissue, which is unknown etiology and
pathogeny. It is usually localized in pelvic and perianal region, and more frequently in female. It is a slow growing tumor but
it is susceptible to local recurrence rate (36–72%). The standard treatment is surgery. There is no clear scientiﬁc evidence about
radiotherapy, but it seems that the RT decreased local recurrence rates.
Objective. We want to analyze effect of postoperative radiotherapy in the case of a patient who was treated in our hospital with
angiomyxoma aggressive recurrence after surgery treatment.
Method. Wedescribe the case of awoman 44 year old, who has the following personal history: Diabetesmellitus, arterial hyperten-
sion, gastritis and obese. Surgical history: uterine ﬁbroid, ovarian cyst, anal ﬁstula and appendectomy. In May 2006, this patient
was diagnosed in CT of a retroperitoneal parauterina tumor which measurement was 10 cm with malignant appearance; it was
removed with the following anatomophatologic outcome: aggressive angiomyxoma. Then in December 2006 and October 2009
the patient presented local recurrence and she had again underwent surgery. In MRI it was a ﬁbrotic tissue between the vesical
and internal obturator which it would be tumor recurrence vs. postsurgical changes. Because of these ﬁndings, we decided to
give her Adjunctive Radiotherapy 50Gy dose about surgical bed with X-ray photons of 15MeV by tridimensional planning and
isocentric technique. During radiotherapy the patient developed some toxicity as radiodermitis grade III and rectitis grade III, so
that we were forced to stop the treatment without achieving target dose 56Gy.
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